CSIMarket
 
Bristol myers Squibb Company  (BMY)
 

News




Bristol Myers Squibb Amplifies Neuroscience Portfolio with Acquisition of Karuna Therapeutics, Spearheading Transformation in Drug Development

Bristol Myers Squibb*s Tender Offer for RayzeBio Expires Amid Challenges in Supplier Revenues and Cost of Sales

Bristol Myers Squibb and RayzeBio Announce Expiration of HSR Act Waiting Period in Pursuit of Transformative Merger in the Oncology Sector.

Bristol Myers Squibb Completes Acquisition of Mirati Therapeutics, Strengthening and Diversifying Oncology Portfolio

Revolutionary Partnership in Cancer Treatment: Bristol Myers Squibb Collaborates with SystImmune to Bring Promising Therapy to Patients

Tempus and Bristol Myers Squibb Partner to Revolutionize Cancer Research through AI and Precision Medicine

Breaking News: Bristol Myers Squibb Sets the Stage for Remarkable Financial Growth, Surging Revenue by a Remarkable 0.622%

Revised headline: Bristol Myers Squibb Company Experiences 24% Increase in Bottom-line Performance over July to September 30, 2023 Timeframe

revenue receded in single digits, at the company over the second quarter of 2023

Lackluster earnings at the Major Pharmaceutical Preparations company all along the first quarter of 2023

Insignificant -3.493 %, contruction in Revenues at over the fiscal interval closing Sep 30 2022

announced that revenue was moderately below the corresponding period a year ago, amid the fiscal third quarter of 2022

Breaking down second quarter of 2022 results, the company*s saw that revenue went up modest

Bristol Myers Squibb Company declared solid Revenue growth, in the financial interval ending March 31 2022

Profitable again in the fourth quarter of 2021 earnings season









Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com